Evidence map›Paper›PMID 42911319›Full record

ReviewCurrent neurology and neuroscience reports2026

When to Start Oral Anticoagulant Therapy Post-Stroke: From Common to Rare Conundrums.

Hrvoje Budinčević, Petra Črnac, Andrija Meštrović, Marija Ernoić, Dora Vogrinc, Juraj Mark Poje, Sandra Zečević Penić, Sandra Vujović

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current neurology and neuroscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hrvoje BudinčevićDepartment of Neurology, Sveti Duh University Hospital, Sveti Duh 64, Zagreb, 10000, Croatia. hbudincevic@gmail.com.
Petra ČrnacDepartment of Neurology, Sveti Duh University Hospital, Sveti Duh 64, Zagreb, 10000, Croatia.
Andrija MeštrovićDepartment of Neurology, Sveti Duh University Hospital, Sveti Duh 64, Zagreb, 10000, Croatia.
Marija ErnoićDepartment of Neurology, Sveti Duh University Hospital, Sveti Duh 64, Zagreb, 10000, Croatia.
Dora VogrincDepartment of Neurology, Sveti Duh University Hospital, Sveti Duh 64, Zagreb, 10000, Croatia.
Juraj Mark PojeDepartment of Neurology, General Hospital Koprivnica "Dr. Tomislav Bardek", Željka Selingera 1, Koprivnica, 480050, Croatia.
Sandra Zečević PenićDepartment of Neurology, University Psychiatric Hospital Sveti Ivan, Jankomir 11, Zagreb, 10000, Croatia.
Sandra VujovićDepartment of Neurology, Clinical Center Montenegro, Ljubljanska bb, Podgorica, 81000, Montenegro.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThis review summarizes recent evidence on when to start oral anticoagulant therapy following stroke, including both common and rare clinical conundrums. RECENT

findingsWhile previous recommendations based on Diener's rule suggested waiting up to 12 days based on stroke severity and neuroradiological findings, newer data support earlier initiation or resumption of anticoagulation, particularly for mild and moderate ischemic strokes, generally within 4 days. In patients with a history of intracerebral hemorrhage, anticoagulation resumption involves weighing thromboembolic risk against recurrent hemorrhage risk, requiring individualized decisions regarding whether and when anticoagulation should be resumed. Clinical recommendations for post-stroke anticoagulation emphasize early, individualized initiation of direct oral anticoagulants for mild-to-moderate ischemic strokes based on neuroimaging. After intracerebral hemorrhage, anticoagulation is generally restarted within 4 to 8 weeks for atrial fibrillation, with earlier resumption potentially warranted in selected high-thromboembolic-risk patients, particularly those with mechanical heart valves.

Indexed as

AnticoagulantsStrokeAdministration, OralAtrial FibrillationHumansAnticoagulantsAnticoagulant therapyAtrial fibrillationStrokeTiming

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.